We characterized spontaneous immune responses against optimized 38-mere arginase-1-derived peptide epitope in cancer patients and healthy donors using ex vivo and in vitro IFNγ ELISPOT and intracellular staining for IFNγ and TNFα. The gene discussed is TNF; the disease is cancer.